Past, Present and Future of A2A Adenosine Receptor Antagonists in the Therapy of Parkinson's Disease

Pharmacology and Therapeutics - United Kingdom
doi 10.1016/j.pharmthera.2011.07.004
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future

2012English

Adenosine A2a Receptor Antagonists Attenuate Striatal Adaptations Following Dopamine Depletion

Neurobiology of Disease
Neurology
2012English

Adenosine A2A Receptor Antagonists Act at the Hyperoxic Phase to Confer Protection Against Retinopathy

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2018English

Hodgkin's Disease; Past, Present and Future.

Journal of clinical and experimental hematopathology : JCEH
Medicine
2001English

Thyroid Hormone Therapy: Past, Present, and Future

Endocrine
2019English

Biomarkers in Alzheimer’s Disease: Past, Present and Future

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2010English

IGF-IR Targeted Therapy: Past, Present and Future

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-Β Generation and Γ-Secretase Activity

PLoS ONE
Multidisciplinary
2017English

Past, Present, and Future of Hormonal Therapy in Recurrent Endometrial Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy